Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models

It has been shown that histone deacetylase (HDAC) inhibitors hold considerable therapeutic potentials for treating neurodegeneration-related diseases including Parkinson disease (PD). Here, we synthesized an HDAC inhibitor named as HGC and examined its neuroprotective roles in PD models. Our results...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bing, Yang, Yinuo, Wang, Yuejun, Zhang, Jing, Ding, Jie, Liu, Xiaoyu, Jin, Yan, Lian, Bolin, Ling, Yong, Sun, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022854/
https://www.ncbi.nlm.nih.gov/pubmed/33851105
http://dx.doi.org/10.1016/j.isci.2021.102302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022854/
https://www.ncbi.nlm.nih.gov/pubmed/33851105
http://dx.doi.org/10.1016/j.isci.2021.102302

Ejemplares similares